---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295535638.md"
description: "In Tuesday's pre-market session, several healthcare stocks saw significant movement. Gainers included Mereo BioPharma (+21.7%), Organigram Global (+18.1%), and Neuronetics (+15.16%), driven largely by recent earnings reports. Conversely, losers featured Tactile Systems Tech (-16.2%), Adagio Medical (-11.32%), and Xtant Medical (-10.32%). Market caps ranged from $2.6 million to $657.2 million across these listed companies."
datetime: "2026-08-11T12:06:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295535638.md)
  - [en](https://longbridge.com/en/news/295535638.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295535638.md)
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **Mereo BioPharma Group** (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million.
-   **Organigram Global** (NASDAQ:OGI) stock rose 18.1% to $1.24. The company's market cap stands at $147.8 million. As per the news, the Q3 earnings report came out today.
-   **Neuronetics** (NASDAQ:STIM) shares rose 15.16% to $2.5. The company's market cap stands at $151.0 million. The company's, Q2 earnings came out today.
-   **Valneva** (NASDAQ:VALN) stock moved upwards by 11.32% to $5.9. The company's market cap stands at $541.2 million.
-   **NeOnc Technologies Hldgs** (NASDAQ:NTHI) stock increased by 10.87% to $3.88. The company's market cap stands at $90.7 million. As per the press release, Q2 earnings came out yesterday.
-   **BioAtla** (NASDAQ:BCAB) stock moved upwards by 9.79% to $3.81. The market value of their outstanding shares is at $5.7 million.

### Losers

-   **Tactile Systems Tech** (NASDAQ:TCMD) stock fell 16.2% to $24.41 during Tuesday's pre-market session. The company's market cap stands at $657.2 million. As per the news, the Q2 earnings report came out yesterday.
-   **Adagio Medical Holdings** (NASDAQ:ADGM) stock declined by 11.32% to $0.66. The market value of their outstanding shares is at $16.5 million.
-   **Xtant Medical Holdings** (AMEX:XTNT) shares decreased by 10.32% to $0.4. The company's market cap stands at $62.5 million. The company's, Q2 earnings came out today.
-   **Jin Medical International** (NASDAQ:ZJYL) shares declined by 10.28% to $2.62. The company's market cap stands at $22.8 million.
-   **Propanc Biopharma** (NASDAQ:PPCB) stock declined by 9.57% to $1.04. The company's market cap stands at $2.6 million.
-   **NexGel** (NASDAQ:NXGL) stock decreased by 8.95% to $0.33. The market value of their outstanding shares is at $3.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [TCMD.US](https://longbridge.com/en/quote/TCMD.US.md)
- [XTNT.US](https://longbridge.com/en/quote/XTNT.US.md)
- [STIM.US](https://longbridge.com/en/quote/STIM.US.md)
- [MREO.US](https://longbridge.com/en/quote/MREO.US.md)
- [OGI.US](https://longbridge.com/en/quote/OGI.US.md)
- [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md)
- [VALN.US](https://longbridge.com/en/quote/VALN.US.md)
- [NTHI.US](https://longbridge.com/en/quote/NTHI.US.md)
- [BCAB.US](https://longbridge.com/en/quote/BCAB.US.md)
- [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md)
- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)
- [NXGL.US](https://longbridge.com/en/quote/NXGL.US.md)
- [PPCBD.US](https://longbridge.com/en/quote/PPCBD.US.md)
- [NXGLW.US](https://longbridge.com/en/quote/NXGLW.US.md)

## Related News & Research

- [Neuronetics Q2 revenue beats estimates on Greenbrook clinic strength](https://longbridge.com/en/news/295533190.md)
- [Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy](https://longbridge.com/en/news/295534982.md)
- [Xtant Medical Q2 revenue falls on asset sales and lost license revenue](https://longbridge.com/en/news/295527365.md)
- [Mereo BioPharma signs option-and-license deal with Sentynl for US rights to alvelestat in AATD lung disease](https://longbridge.com/en/news/295533220.md)
- [Xtant Medical hosted annual shareholder meeting, quorum met 74.47% of shares](https://longbridge.com/en/news/295274008.md)